(Q33902891)

29 July 2017

1 reference

title

Chemoprevention: general perspective (English)

1 reference

29 July 2017

Shureiqi I

1

1 reference

29 July 2017

Reddy P

series ordinal

2

1 reference

29 July 2017

Brenner DE

series ordinal

3

1 reference

29 July 2017

publication date

1 March 2000

1 reference

Critical Reviews in Oncology Hematology

29 July 2017

published in

1 reference

29 July 2017

volume

33

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

157-167

1 reference

29 July 2017

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Recent advances in chemoprevention of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

1 reference

7 January 2021

Cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Suppression of tumour development by substances derived from the diet--mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Principles of human chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

The significance of matrix metalloproteinases during early stages of tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Mechanisms of apoptosis avoidance in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

The genetic analysis of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Cancer cells exhibit a mutator phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Genetic alterations during colorectal-tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Chemoprevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Preclinical drug development paradigms for chemopreventives

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Aberrant crypt foci of the colon as precursors of adenoma and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

K-ras mutations in putative preneoplastic lesions in human colon

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Pathogenesis of polyps (adenomas)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Colon carcinogenesis models for chemoprevention studies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Sulindac suppresses tumorigenesis in the Min mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Use of alternative medicine by women with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Quality of life research: clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Patient adherence to prescribed therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

In Search of the Gold Standard for Compliance Measurement

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Physicians' recommendations for mammography: do tailored messages make a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Models for early chemoprevention trials in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experience

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Cancer chemoprevention: progress and promise

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

The clinical utility of risk factor data

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

A clinician-friendly computer program for calculating breast cancer risk using the Gail and Claus models

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Blood pressure, systolic and diastolic, and cardiovascular risks. US population data

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Treatment strategies for management of serum lipids: lessons learned from lipid metabolism, recent clinical trials, and experience with the HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

An evaluation of a measure of the proportion of the treatment effect explained by a surrogate marker.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Use of tumour markers in monitoring the course of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Increased CA 125 in a patient with tuberculous peritonitis: case report and review of published works

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

The performance of screening tests for ovarian cancer: results of a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

The Clinical Usefulness of Prostate Specific Antigen: Update 1994

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Biomarkers as intermediate end points in chemoprevention trials

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Precursors to skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Natural history of cervical neoplasia: consistent results obtained by an identification technique

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Premalignant lesions in the mouth

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Strategies for chemoprevention of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Cancer, crash sites, and the new genetics of neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900072-4

7 January 2021

10.1016/S1040-8428(99)00072-4

Identifiers

DOI

1 reference

29 July 2017

1 reference